Differences were found between the expression of ERα 39 (88%) and ERβ 16 (36%) (p = 0.007); the expression of bcl-2 was seen in 35 (79.5%) invasive breast carcinomas (Table 1). The gene discussed is ESR2; the disease is invasive breast carcinoma.